LY300503

LY300503 is an enantiomer of LY191704. LY191704 is a human type I 5α-reductase inhibitor[1][2].

Product Specifications

CAS Number

[148905-79-7]

UNSPSC

12352005

Target

5 alpha Reductase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/ly300503.html

Solubility

10 mM in DMSO

Smiles

CN1[C@]2([H])[C@](CCC1=O)([H])C3=CC=C(Cl)C=C3CC2

Molecular Formula

C14H16ClNO

Molecular Weight

249.74

References & Citations

[1]Farid NA, et, al. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY191704, a human type 1 5 alpha-reductase inhibitor, in plasma. J Chromatogr B Biomed Sci Appl.|[2]Farid NA, et, al. Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs. Drug Metab Dispos. 1996 Oct;24 (10) :1162-5.